Eden Biodesign LLC
General
Total Cases14
Active Cases2
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
E
PTAB
L5
A
CAFC
L5
E
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
12/18/24 | Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding status. (Tigan, Jeremy) Modified on 12/18/2024 (nms). (Entered: 12/18/2024) | |
12/17/24 | CORRECTING ENTRY: The stipulation filed at D.I. 495 on 12/17/2024, has been removed per the filer's request as it contained errors. (nms) (Entered: 12/17/2024) | |
12/11/24 | STIPULATION and Proposed Order - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 12/11/2024 (nms). (Entered: 12/11/2024) | |
12/11/24 | SO ORDERED, re [494] STIPULATION and Proposed Order (*Reset Deadlines: Status Report due by 12/18/2024). Signed by Judge Richard G. Andrews on 12/11/2024. (nms) (Entered: 12/11/2024) | |
12/02/24 | SO ORDERED Granting [490] Stipulation and Proposed Order (*Sun Pharmaceutical Industries Limited terminated). Signed by Judge Richard G. Andrews on 12/2/2024. (nms) (Entered: 12/02/2024) | |
11/27/24 | ORAL ORDER: A joint status letter is due by December 11, 2024. Ordered by Judge Richard G. Andrews on 11/27/2024. (nms) (Entered: 11/27/2024) | |
11/27/24 | MANDATE of USCA as to [488] Notice of Appeal (Federal Circuit), filed by Allergan USA, Inc., Eden Biodesign, LLC, Allergan Holdings Unlimited Company. USCA Decision: Reversed. (Attachments: # [1] Opinion, # [2] Judgment)(nms) (Entered: 11/27/2024) | |
11/27/24 | STIPULATION of Dismissal between Plaintiffs and Sun Pharmaceutical Industries Limited, by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Tigan, Jeremy) Modified on 11/27/2024 (nms). (Entered: 11/27/2024) | |
11/26/24 | SO ORDERED Granting [80] Stipulation and Proposed Order (*Party Sun Pharmaceutical Industries Limited terminated). Signed by Judge Richard G. Andrews on 11/26/2024. (nms) (Entered: 11/26/2024) | |
11/26/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,097,187 B2. (Attachments: # [1] Order)(nms) (Entered: 11/26/2024) |